Phenobarbital

catenin (cadherin associated protein), beta 1 ; Mus musculus







19 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31836555 Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital. 2020 Jan 30 1
2 32735318 Comparison of the Hepatic Effects of Phenobarbital in Chimeric Mice Containing Either Rat or Human Hepatocytes With Humanized Constitutive Androstane Receptor and Pregnane X Receptor Mice. 2020 Oct 1 1
3 32749219 A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling. 2020 Aug 4 1
4 31615920 Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotion. 2019 Oct 1
5 28580885 β-catenin Mutations Are Not Involved in Early-stage Hepatocarcinogenesis Induced by Protoporphyrinogen Oxidase Inhibitors in Mice. 2017 Jun 1
6 26351921 Phenobarbital inhibits calpain activity and expression in mouse hepatoma cells. 2016 Jan 3
7 26838046 Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice. 2016 Jun 5
8 27693619 Inhibition of β-catenin signaling by phenobarbital in hepatoma cells in vitro. 2016 Aug 31 12
9 24464994 Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion. 2014 Apr 1
10 24863967 Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. 2014 Aug 1 1
11 23091169 Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion. 2013 Feb 1
12 22761897 β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice. 2012 2
13 21047994 Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen. 2011 Jan 7
14 20886225 Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice. 2010 Nov 3
15 16782779 PCB 153, a non-dioxin-like tumor promoter, selects for beta-catenin (Catnb)-mutated mouse liver tumors. 2006 Sep 2
16 15471898 A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. 2005 Jan 1
17 14742323 Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital. 2004 Jun 6
18 12384525 Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. 2002 Oct 15 3
19 11753661 Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. 2001 Nov 22 1